BB Biotech Stock
StockStockPrice
Historical dividends and forecast
BB Biotech has so far distributed $2.209 in 2024. The next dividend will be paid on 27.03.2025
CHART BY
Frequently asked questions
What is BB Biotech's market capitalization?
What is BB Biotech's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for BB Biotech?
What are the analyst ratings and target price for BB Biotech's stock?
What is BB Biotech's revenue over the trailing twelve months?
What is the EBITDA for BB Biotech?
What is the free cash flow of BB Biotech?
What is the 5-year beta of BB Biotech's stock?
What is the free float of BB Biotech's shares?
Financials
Market Cap
$2.50B5Y beta
1.10EPS (TTM)
$2.573Free Float
53.87MP/E ratio (TTM)
17.56Revenue (TTM)
$306.96MEBITDA (TTM)
$264.15MFree Cashflow (TTM)
$41.38MPricing
Analyst Ratings
The price target is $63.55 and the stock is covered by 5 analysts.
Buy
5
Hold
0
Sell
0
Information
BB Biotech AG is a Switzerland-based investment company, which principal activity is to invest in companies active in the biotechnology industry. BB Biotech AG invests mainly in companies operating in such sectors as oncology, infectious diseases, cardiovascular diseases, metabolic diseases and autoimmune diseases. The Company’s portfolio comprises between 20 and 35 companies and includes such companies as Celgene, Actelion, Vertex Pharmaceuticals, Gilead, Novo Nordisk, Incyte, Isis Pharmaceuticals, Immunogen, Halozyme Therapeutics, Ariad Pharmaceuticals, Biomarin Pharmaceutical, Alexion Pharmaceuticals, Optimer Pharmaceuticals, Achillion Pharmaceuticals, Swedish Orphan Biovitrum, Dendreon, Bavarian Nordic, Lupin, Glenmark Pharmaceuticals, Strides Arcolab, Endocyte, Probiodrug, and Idenix Pharmaceuticals.
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker